Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
Open accessAbstract
In an inducible oncogenesis model, the miR-200 family is inhibited during CSC formation but not transformation, and inhibition of miR-200b increases CSC formation. Interestingly, miR-200b directly targets Suz12, a subunit of a polycomb repressor complex (PRC2). Loss of miR-200 during CSC formation increases Suz12 expression, Suz12 binding, H3-K27 trimethylation, and Polycomb-mediated repression of the E-cadherin gene. miR-200b expression or Suz12 depletion blocks the formation and maintenance of mammospheres, and in combination with chemotherapy suppresses tumor growth and prolongs remission in mouse xenografts. Conversely, ectopic expression of Suz12 in transformed cells is sufficient to generate CSCs. The miR-200b-Suz12-cadherin pathway is important for CSC growth and invasive ability in genetically distinct breast cancer cells, and its transcriptional signature is observed in metastatic breast tumors. The interaction between miR-200 and Suz12 is highly conserved, suggesting that it represents an ancient regulatory mechanism to control the growth and function of stem cells.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinical responses have been reported in a small number of patients with SMARCB1-mutant tumours.
“Clinical responses have also been reported in a small number of patients with SMARCB1-mutant tumours 164 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,623 · see citing works
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852 · see citing works
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775 · see citing works
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · see citing works
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,518 · see citing works
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,499 · see citing works
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413 · see citing works
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · see citing works
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,238 · see citing works
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,906 · see citing works
Burk, U., Schubert, J., Wellner, U. F., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO Reports · doi:10.1038/embor.2008.74 · Cited by 1,722 · see citing works
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U. F., Schubert, J., Burk, U., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D. S., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,686 · see citing works
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,642 · see citing works
Soule, H. D., Maloney, T., Wolman, S. R., Peterson, W., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., & Brooks, S. C. (1990) · PubMed · Cited by 1,527 · see citing works
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
Önder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,527 · see citing works
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374 · see citing works
Self-citationMechanisms of Polycomb gene silencing: knowns and unknowns
Simon, J. A., & Kingston, R. E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2763 · Cited by 1,320 · see citing works
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N. A., Dalerba, P. D., Qian, D., Diehn, M., Liu, H., Panula, S., Chiao, E. T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,205 · see citing works
Role of the polycomb protein EED in the propagation of repressive histone marks
Margueron, R., Justin, N., Ohno, K., Sharpe, M. L., Son, J., Drury, W. J., Voigt, P., Martin, S. R., Taylor, W. R., Marco, V. D., et al. (2009) · Nature · doi:10.1038/nature08398 · Cited by 1,203 · see citing works
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115 · see citing works
Self-citationBracken, C., Gregory, P. A., Kolesnikoff, N., Bert, A., Wang, J., Shannon, M., & Goodall, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,099 · see citing works
Direct cell reprogramming is a stochastic process amenable to acceleration
Hanna, J. H., Saha, K., Pando, B., van Zon, J. S., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 1,006 · see citing works
Polycomb silencing mechanisms and the management of genomic programmes
Schwartz, Y. B., & Pirrotta, V. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1981 · Cited by 868 · see citing works
Nishino, J., Kim, I., Chada, K. K., & Morrison, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.017 · Cited by 623 · see citing works
Ruby, J. G., Stark, E., Johnston, W. K., Kellis, M., Bartel, D. P., & Lai, E. C. (2007) · Genome Research · doi:10.1101/gr.6597907 · Cited by 591 · see citing works
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Bracken, A. P., & Helin, K. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2736 · Cited by 562 · see citing works
Cancer stem cells in solid tumors
Ailles, L., & Weissman, I. L. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.007 · Cited by 510 · see citing works
Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor
Herranz, N., Pasini, D., Diaz, V. M., Francı́, C., Gutiérrez, A., Dave, N., Escrivà, M., Hernández‐Muñoz, I., Croce, L. D., Helin, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-08 · Cited by 437 · see citing works
Tevosian, S. G., Deconinck, A. E., Tanaka, M., Schinke, M., Litovsky, S. H., Izumo, S., Fujiwara, Y., & Orkin, S. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80885-5 · Cited by 419 · see citing works
Adam, L., Zhong, M., Choi, W., Wei, Q., Nicoloso, M. S., Arora, A., Calin, G. A., Wang, H., Siefker-Radtke, A. O., McConkey, D. J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 410 · see citing works
Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells
Bao, S., Tang, F., Li, X., Hayashi, K., Gillich, A., Lao, K., & Surani, M. A. (2009) · Nature · doi:10.1038/nature08534 · Cited by 384 · see citing works
Hirsch, H. A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S. A., Bulyk, M. L., Tsichlis, P. N., Liu, X. S., & Struhl, K. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.022 · Cited by 359 · see citing works
Self-citationMammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Grimshaw, M. J., Cooper, L., Papazisis, K. T., Coleman, J., Bohnenkamp, H. R., Chiapero-Stanke, L., Taylor‐Papadimitriou, J., & Burchell, J. (2008) · Breast Cancer Research · doi:10.1186/bcr2106 · Cited by 340 · see citing works
Suz12 binds to silenced regions of the genome in a cell-type-specific mannerPreprint
Squazzo, S. L., O’Geen, H., Komashko, V., Krig, S. R., Jin, V. X., Jang, S.-W., Margueron, R., Reinberg, D., Green, R., & Farnham, P. (2006) · Genome Research · doi:10.1101/gr.5306606 · Cited by 310 · see citing works
Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K
Hyun, S., Lee, J., Jin, H., Nam, J., Namkoong, B., Lee, G., Chung, J., & Kim, V. N. (2009) · Cell · doi:10.1016/j.cell.2009.11.020 · Cited by 309 · see citing works
Yang, A., Zhu, Z., Kapranov, P., McKeon, F., Church, G. M., Gingeras, T., & Struhl, K. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.10.018 · Cited by 277 · see citing works
Self-citationMicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPreprint
Olson, P., Lü, J., Zhang, H., Shai, A., Chun, M. G. H., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 259 · see citing works
Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
Villa, R., Pasini, D., Gutiérrez, A., Morey, L., Occhionorelli, M., Viré, E. A., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.009 · Cited by 247 · see citing works
Su(z)12, a novelDrosophilaPolycomb group gene that is conserved in vertebrates and plants
Birve, A., Sengupta, A. K., Beuchle, D., Larsson, J., Kennison, J. A., Rasmuson-Lestander, Å., & Müller, J. (2001) · Development · doi:10.1242/dev.128.17.3371 · Cited by 216 · see citing works
Bendoraite, A., Knouf, E. C., Garg, K. S., Parkin, R. K., Kroh, E. M., O'Briant, K. C., Ventura, A. P., Godwin, A. K., Karlan, B. Y., Drescher, C. W., et al. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.08.009 · Cited by 199 · see citing works
Myc‐regulated microRNAs attenuate embryonic stem cell differentiation
Lin, C. A., Jackson, A. L., Guo, J., Linsley, P. S., & Eisenman, R. N. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.254 · Cited by 183 · see citing works
Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
Hussain, M., Rao, M., Humphries, A. E., Hong, J. A., Liu, F., Yang, M., Caragacianu, D. L., & Schrump, D. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2807 · Cited by 162 · see citing works
EZH2 and Histone 3 Trimethyl Lysine 27 Associated with Il4 and Il13 Gene Silencing in TH1 Cells
Koyanagi, M., Baguet, A., Martens, J. H. A., Margueron, R., Jenuwein, T., & Bix, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504766200 · Cited by 155 · see citing works
BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases
Hoenerhoff, M. J., Chu, I. M., Barkan, D., Liu, Z., Datta, S., Dimri, G. P., & Green, J. E. (2009) · Oncogene · doi:10.1038/onc.2009.165 · Cited by 101 · see citing works
Metsuyanim, S., Pode‐Shakked, N., Schmidt-Ott, K. M., Keshet, G. I., Rechavi, G., Blumental, D., & Dekel, B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0322 · Cited by 80 · see citing works
Control of Stemness by Fibroblast Growth Factor Signaling in Stem Cells and Cancer Stem Cells
Gotoh, N. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809787169048 · Cited by 71 · see citing works
Allen, M. L., & Antoniou, M. (2007) · Epigenetics · doi:10.4161/epi.2.4.5231 · Cited by 62 · see citing works
Self-citationIdentification of tumorigenic retinal stem‐like cells in human solid retinoblastomas
Zhong, X., Li, Y., Peng, F., Huang, B. Q., Lin, J., Zhang, W., Zheng, J., Jiang, R., Song, G., & Ge, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22880 · Cited by 57 · see citing works
Aziz, N. A., Cherwinski, H. M., & McMahon, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1101 · Cited by 55 · see citing works
Pizzatti, L., Binato, R., Cofré, J., Gomes, B. E., Dobbin, J., Haussmann, M. E., D'Azambuja, D., Bouzas, L. F., & Abdelhay, E. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20722 · Cited by 32 · see citing works
Furuno, K., Masatsugu, T., Sonoda, M., Sasazuki, T., & Yamamoto, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.014 · Cited by 30 · see citing works
In vivo analysis of Drosophila SU(Z)12 function
Chen, S., Birve, A., & Rasmuson-Lestander, Å. (2007) · Molecular Genetics and Genomics · doi:10.1007/s00438-007-0304-3 · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492 · see citing works
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487 · see citing works
Leva, G. D., Garofalo, M., & Croce, C. M. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,669 · see citing works
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,159 · see citing works
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,120 · see citing works
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y., Lee, S., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 1,013 · see citing works
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y., Byers, L. A., Zhang, X., Yi, X., Dwyer, D. W., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 972 · see citing works
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
Scheel, C., & Weinberg, R. A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.001 · Cited by 872 · see citing works
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869 · see citing works
Bertoli, G. R., Cava, C., & Castiglioni, I. (2015) · Theranostics · doi:10.7150/thno.11543 · Cited by 818 · see citing works
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 642 · see citing works
Self-citationKorpal, M., Ell, B. J., Buffa, F., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y.-L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636 · see citing works
Non-coding RNAs as regulators of embryogenesis
Pauli, A., Rinn, J. L., & Schier, A. F. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2904 · Cited by 623 · see citing works
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3265 · Cited by 622 · see citing works
Understanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 559 · see citing works
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M. J., Belle, L., Farshid, G., Lim, Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552 · see citing works
The roles of DNA, RNA and histone methylation in ageing and cancer
Michalak, E. M., Burr, M. L., Bannister, A. J., & Dawson, M. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0143-1 · Cited by 549 · see citing works
Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K. A., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491 · see citing works
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Mateescu, B., Batista, L., Cardon, M., Gruosso, T., de Feraudy, Y., Mariani, O., Nicolas, A., Meyniel, J.-P., Cottu, P., Sastre-Garau, X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2512 · Cited by 438 · see citing works
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 451 · see citing works
Self-citationHirsch, H. A., Iliopoulos, D., & Struhl, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221055110 · Cited by 440 · see citing works
Self-citationMaintaining cell identity: PRC2-mediated regulation of transcription and cancer
Comet, I. V., Riising, E. M., Leblanc, B., & Helin, K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.83 · Cited by 428 · see citing works
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S. Y., Han, H., Shah, M., Rodriguez‐Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 400 · see citing works
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
Eun, K., Ham, S. W., & Kim, H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.3.222 · Cited by 388 · see citing works
Humphries, B. A., & Yang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3052 · Cited by 343 · see citing works
Kong, D., Li, Y., Wang, Z. P., & Sarkar, F. H. (2011) · Cancers · doi:10.3390/cancers30100716 · Cited by 346 · see citing works
MiR-200, a new star miRNA in human cancer
Feng, X., Wang, Z., Fillmore, R. A., & Xi, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.004 · Cited by 342 · see citing works
Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
Sciacovelli, M., & Frezza, C. (2017) · FEBS Journal · doi:10.1111/febs.14090 · Cited by 324 · see citing works
Molecular Pathogenesis of Cholangiocarcinoma
Labib, P. L. Z., Goodchild, G., & Pereira, S. P. (2019) · BMC Cancer · doi:10.1186/s12885-019-5391-0 · Cited by 314 · see citing works
Bao, B., Ali, S. S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., Kong, D., Ahmad, A., Li, Y., Padhyé, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2182 · Cited by 297 · see citing works
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
Liu, Y.-N., Yin, J., Abou-Kheir, W. G., Hynes, P. G., Casey, O. M., Fang, L., Yi, M., Stephens, R. M., Seng, V., Sheppard, H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.58 · Cited by 294 · see citing works
tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer
Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W., Zhang, Q., Zhang, L., Xue, Z., Li, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3146 · Cited by 295 · see citing works
Bao, B., Ahmad, A., Azmi, A. S., Ali, S. S., & Sarkar, F. H. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1425s61 · Cited by 287 · see citing works
Au, S. L., Wong, C. C., Lee, J. M., Fan, D. N.-Y., Tsang, F. H., Ng, I. O., & Wong, C. (2012) · Hepatology · doi:10.1002/hep.25679 · Cited by 285 · see citing works
Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
Skrypek, N., Goossens, S., Smedt, E. D., Vandamme, N., & Berx, G. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.004 · Cited by 270 · see citing works
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Howe, E. N., Cochrane, D. R., & Richer, J. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2867 · Cited by 248 · see citing works
Common stemness regulators of embryonic and cancer stem cells
Hadjimichael, C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1150 · Cited by 246 · see citing works
Targeting cancer stem cells to suppress acquired chemotherapy resistance
Vidal, S. J., Rodríguez-Bravo, V., Galsky, M. D., Cordon‐Cardo, C., & Domenech, J. M. D. (2013) · Oncogene · doi:10.1038/onc.2013.411 · Cited by 242 · see citing works
Jurmeister, S., Baumann, M., Balwierz, A., Keklikoglou, I., Ward, A., Uhlmann, S., Zhang, J. D., Wiemann, S., & Şahin, Ö. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06212-11 · Cited by 228 · see citing works
Targeting EZH2 in cancer therapy
Yamagishi, M., & Uchimaru, K. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000390 · Cited by 224 · see citing works
Alves, C. P., Fonseca, A. S., Muys, B. R., Bueno, R. D. B. E. L., Bürger, M. C., de Souza, J. E. S., Valente, V., Zago, M. A., & Silva, W. A. (2013) · Stem Cells · doi:10.1002/stem.1547 · Cited by 218 · see citing works
Luo, M., Brooks, M. D., & Wicha, M. S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211120604 · Cited by 217 · see citing works
Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Cao, Q., Mani, R. S., Ateeq, B., Dhanasekaran, S. M., Asangani, I. A., Prensner, J. R., Kim, J. H., Brenner, J. C., Jing, X., Cao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.016 · Cited by 204 · see citing works
Epigenetic alterations involved in cancer stem cell reprogramming
Muñoz, P., Iliou, M., & Esteller, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.006 · Cited by 211 · see citing works
Hwang‐Verslues, W. W., Chang, P.-H., Wei, P.-C., Yang, C.-Y., Huang, C.-K., Kuo, W.-H., Shew, J.-Y., Chang, K.-J., Lee, E.-H., & Lee, W.-H. (2011) · Oncogene · doi:10.1038/onc.2010.618 · Cited by 199 · see citing works
MicroRNAs and cancer: Key paradigms in molecular therapy (Review)
Tan, W., Liu, B., Qu, S., Liang, G., Luo, W., & Gong, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7638 · Cited by 200 · see citing works
Lim, Y., Wright, J. A., Attema, J. L., Gregory, P. A., Bert, A. G., Smith, E., Thomas, D., Drew, P. A., Khew‐Goodall, Y., & Goodall, G. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.122275 · Cited by 190 · see citing works
Targeting cancer stem cells by curcumin and clinical applications
Li, Y., & Zhang, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.012 · Cited by 190 · see citing works
Cavallari, I., Ciccarese, F., Sharova, E., Urso, L., Raimondi, V., Silic‐Benussi, M., D’Agostino, D. M., & Ciminale, V. (2021) · Cancers · doi:10.3390/cancers13235874 · Cited by 190 · see citing works
Epigenetic alteration and microRNA dysregulation in cancer
Suzuki, H., Maruyama, R., Yamamoto, E., & Kai, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00258 · Cited by 188 · see citing works
MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell lines
Liu, X., Wang, C., Chen, Z., Jin, Y., Wang, Y., Kolokythas, A., Dai, Y., & Zhou, X. C. (2011) · Biochemical Journal · doi:10.1042/bj20111006 · Cited by 181 · see citing works
Kurashige, J., Kamohara, H., Watanabe, M., Hiyoshi, Y., Iwatsuki, M., Tanaka, Y., Kinoshita, K., Saito, S., Baba, Y., & Baba, H. A. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2217-6 · Cited by 180 · see citing works
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
Roybal, J. D., Zang, Y., Ahn, Y., Yang, Y., Gibbons, D. L., Baird, B. N., Alvarez, C., Thilaganathan, N., Liu, D. D., Saintigny, P., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0497 · Cited by 174 · see citing works
Role of microRNAs in breast cancer
Singh, R., & Mo, Y. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23296 · Cited by 173 · see citing works
The Epigenetic Hallmarks of Cancer
Esteller, M., Dawson, M. A., Kadoch, C., Rassool, F. V., Jones, P. A., & Baylin, S. B. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0296 · Cited by 184 · see citing works
Drasin, D. J., Robin, T. P., & Ford, H. L. (2011) · Breast Cancer Research · doi:10.1186/bcr3037 · Cited by 168 · see citing works
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 167 · see citing works
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
Cano, A., Díaz‐López, A., & Moreno‐Bueno, G. (2014) · Cancer Management and Research · doi:10.2147/cmar.s38156 · Cited by 166 · see citing works
Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis
Wang, Y., & Zhou, B. P. (2013) · Cancer Hallmarks · doi:10.1166/ch.2013.1004 · Cited by 162 · see citing works
A step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 161 · see citing works
Self-citationPolycomb preferentially targets stalled promoters of coding and noncoding transcriptsPreprint
Enderle, D., Beisel, C., Stadler, M. B., Gerstung, M., Athri, P., & Paro, R. (2010) · Genome Research · doi:10.1101/gr.114348.110 · Cited by 156 · see citing works
MicroRNAs Contribute to Breast Cancer Invasiveness
Fridrichová, I., & Zmetakova, I. (2019) · Cells · doi:10.3390/cells8111361 · Cited by 159 · see citing works
MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
Yu, S.-J., Hu, J.-Y., Kuang, X.-Y., Luo, J.-M., Hou, Y., Di, G., Wu, J., Shen, Z., Song, H.-Y., & Shao, Z.-M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1959 · Cited by 159 · see citing works
Keely, P. J. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9226-0 · Cited by 158 · see citing works
Metabolic Adaptations in Cancer Stem Cells
Yadav, U. P., Singh, T., Kumar, P., Sharma, P., Kaur, H., Sharma, S., Singh, S., Kumar, S., & Mehta, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01010 · Cited by 153 · see citing works
Ding, L., Gu, H., Xiong, X., Ao, H., Cao, J., Lin, W.-S., Yu, M., Lin, J., & Cui, Q. (2019) · Cells · doi:10.3390/cells8121492 · Cited by 156 · see citing works
miRNAs and cancer: An epigenetics view
Malumbres, M. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.005 · Cited by 152 · see citing works
Regulation of breast cancer metastasis signaling by miRNAs
Petri, B. J., & Klinge, C. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09905-7 · Cited by 154 · see citing works
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 148 · see citing works
Overview of Cancer Stem Cells and Stemness for Community Oncologists
Lathia, J. D., & Liu, H. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0508-3 · Cited by 147 · see citing works
Epigenetics and MicroRNAs in Cancer
Ramassone, A., Pagotto, S., Veronese, A., & Visone, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020459 · Cited by 149 · see citing works
Epigenetic regulation of epithelial–mesenchymal transition
Sun, L., & Fang, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2303-1 · Cited by 145 · see citing works
Chiou, G., Cherng, J., Hsu, H., Wang, M., Tsai, C., Lu, K., Chien, Y., Hung, S., Chen, Y., Wong, C.-I., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.014 · Cited by 144 · see citing works
Augsburger, D., Nelson, P. J., Kalinski, T., Udelnow, A., Knösel, T., Hofstetter, M. M., Qin, J. W., Wang, Y., Gupta, A. S., Bonifatius, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20136 · Cited by 144 · see citing works
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
Polytarchou, C., Iliopoulos, D., & Struhl, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212811109 · Cited by 142 · see citing works
Self-citationSingh, A. K., Arya, R. K., Maheshwari, S., Singh, A., Meena, S., Pandey, P., Dormond, O., & Datta, D. B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28804 · Cited by 141 · see citing works
Identifying a miRNA signature for predicting the stage of breast cancer
Sathipati, S. Y., & Ho, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-34604-3 · Cited by 137 · see citing works
Genome‐wide identification of miR‐200 targets reveals a regulatory network controlling cell invasion
Bracken, C. P., Li, X., Wright, J. A., Lawrence, D., Pillman, K. A., Salmanidis, M., Anderson, M. A., Dredge, B. K., Gregory, P. A., Tsykin, A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488641 · Cited by 134 · see citing works
Ren, D., Wang, M., Guo, W., Huang, S., Wang, Z., Zhao, X., Du, H., Song, L., & Peng, X. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2001-y · Cited by 135 · see citing works
Cai, W., Wei, T.-Z., Luo, Q., Wu, Q.-W., Liu, Q., Yang, M., Ye, G.-D., Wu, J., Chen, Y., Sun, G., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.123810 · Cited by 131 · see citing works
Bakirtzi, K., Hatziapostolou, M., Karagiannides, I., Polytarchou, C., Jaeger, S. A., Iliopoulos, D., & Pothoulakis, C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.038 · Cited by 130 · see citing works
Self-citationPerdigão-Henriques, R., Petrocca, F., Altschuler, G. M., Thomas, M., Le, M. T. N., Tan, S. M., Hide, W., & Lieberman, J. (2015) · Oncogene · doi:10.1038/onc.2015.69 · Cited by 123 · see citing works
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
Li, X., Roslan, S., Johnstone, C. N., Wright, J. A., Bracken, C. P., Anderson, M. A., Bert, A. G., Selth, L. A., Anderson, R. L., Goodall, G. J., et al. (2013) · Oncogene · doi:10.1038/onc.2013.370 · Cited by 125 · see citing works
Lee, S.-R., Roh, Y.-G., Kim, S., Lee, J., Seol, S., Lee, H.-H., Kim, W.-T., Kim, W., Heo, J., Cha, H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2680 · Cited by 123 · see citing works
Crosstalk among Epigenetic Pathways Regulates Neurogenesis
Jobe, E. M., McQuate, A. L., & Zhao, X. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00059 · Cited by 124 · see citing works
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
Amodio, N., Rossi, M., Raimondi, L., Pitari, M. R., Botta, C., Tagliaferri, P., & Tassone, P. (2015) · Oncotarget · doi:10.18632/oncotarget.3805 · Cited by 121 · see citing works
The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity
Howe, E. N., Cochrane, D. R., & Richer, J. K. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9244-6 · Cited by 120 · see citing works
The emerging role of microRNAs in schizophrenia and autism spectrum disorders
Mellios, N., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00039 · Cited by 120 · see citing works
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Goh, J. N., Loo, S. Y., Datta, A., Siveen, K. S., Yap, W. N., Cai, W., Shin, E. M., Wang, C., Kim, J. E., Chan, M., et al. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12176 · Cited by 118 · see citing works
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer
Suresh, R., Ali, S. S., Ahmad, A., Philip, P. A., & Sarkar, F. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_4 · Cited by 116 · see citing works
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
Yang, Y., Ahn, Y., Chen, Y., Tan, X., Guo, L., Gibbons, D. L., Ungewiss, C., Peng, D. H., Liu, X., Lin, S. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72171 · Cited by 115 · see citing works
MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer
Zhao, L., Sun, Y., Hou, Y., Peng, Q., Wang, L., Luo, H., Tang, X., Zeng, Z., & Liu, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.005 · Cited by 115 · see citing works
Ming-li, H., Liu, M., Wang, Y., Mo, Z., Bi, X., Liu, Z., Fan, Y., Chen, X., & Wu, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1195-5 · Cited by 114 · see citing works
MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
Peruzzi, P., Bronisz, A., Nowicki, M. O., Wang, Y., Ogawa, D., Price, R. L., Nakano, I., Kwon, C.-H., Hayes, J. L., Lawler, S. E., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not055 · Cited by 114 · see citing works
Hilakivi-Clarke, L. A. (2014) · Breast Cancer Research · doi:10.1186/bcr3649 · Cited by 112 · see citing works
Dejean, E., Renalier, M.-H., Foisseau, M., Agirre, X., Joseph, N., Silva, G. R. D. P., Saati, T. A., Soulier, J., Desjobert, C., Lamant, L., et al. (2011) · Leukemia · doi:10.1038/leu.2011.168 · Cited by 111 · see citing works
Recent trends in targeting miRNAs for cancer therapy
Shah, V., & Shah, J. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13351 · Cited by 113 · see citing works
Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review
Mizuguchi, Y., Takizawa, T., Yoshida, H., & Uchida, E. (2015) · Hepatology Research · doi:10.1111/hepr.12606 · Cited by 108 · see citing works
Tsouko, E., Wang, J., Frigo, D. E., Aydoğdu, E., & Williams, C. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv087 · Cited by 107 · see citing works
Filios, S. R., Xu, G., Chen, J., Hong, K.-H., Gu, J., & Shalev, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592360 · Cited by 106 · see citing works
- Authors
- Iliopoulos, D., Lindahl-Allen, M., Polytarchou, C., Hirsch, H. A., Tsichlis, P. N., & Struhl, K.
- Affiliations
- Harvard University (US)
- Tufts Medical Center (US)
- Corresponding author
- Struhl, Kevin
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 39
- Issue
- 5
- Pages
- 761-772
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC2938080
- OpenAlex
- W2050306367
- Cited by
- 399
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 21 · 2019: 29 · 2018: 16 · 2017: 24 · 2016: 23 · 2015: 34 · 2014: 51 · 2013: 52 · 2012: 41
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- China Scholarship Council
- National Cancer Institute (R01CA107486, CA 57486, CA107486, R01CA057436)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- miR-200b, SUZ12, cancer stem cells, polycomb repressive complex 2, H3K27me3, E-cadherin, breast cancer, mammospheres, chemoresistance, metastasis, microRNA target regulation
- MeSH terms
- Animals, Breast Neoplasms, Carrier Proteins, Female, Humans, Mice, Nude, Neoplasm Proteins, Neoplasm Transplantation, Nuclear Proteins, Repressor Proteins, RNA, Neoplasm, Transcription Factors, Transplantation, Heterologous, Neoplastic Stem Cells, Cadherins, MicroRNAs, Cell Line, Tumor, Mice, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
